Atlas Trials

Capecitabine With Digoxin for Metastatic Breast Cancer

Clinical trial NCT01887288 · TERMINATED

Trial details

NCT number
NCT01887288
Sponsor
Western Regional Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-04-01
Primary completion
2015-11-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.